Previous 10 | Next 10 |
2024-06-28 12:57:07 ET Summary Walgreens Boots Alliance stock has declined over 83% from its all-time high, underperforming the S&P 500 and competitor CVS Health. The company reported mediocre third quarter results, but lowered full-year guidance once again. Although the s...
2024-06-28 11:57:46 ET Read the full article on Seeking Alpha For further details see: UnitedHealth, Humana seen as managed care beneficiaries in second Trump term
2024-06-28 08:27:06 ET Summary The June/July 2024 edition of Fortune Magazine revealed the 500 biggest U.S. companies by-revenue and profits. Dogcatcher’s quest for dividend buys focused-on 66 industry-eaders (IL) using YCharts 6/26/24 data. Those 66 industry-leaders were s...
2024-06-27 21:02:00 ET CVS Health (NYSE: CVS) stock price is imploding as concerns about the pharmacy business continue. It has already plunged by more than 43% from its 2022 highs and is hovering at its lowest point since November 2020. Pharmacy woes are continuing The pharmacy...
2024-06-27 11:54:44 ET More on Cencora, CVS Health, etc. Walgreens Plummets: Avoid At All Costs Cencora: Long-Term Compounder With Mouth-Watering Economics Walgreens: Beware The Value Trap Ahead Of Earnings Biggest stock movers today: WBA, BB, MU, and more ...
2024-06-27 08:27:54 ET Rite Aid ( OTC:RADCQ ) is seeking approval from a bankruptcy court for its restructuring plan that will cut $2B in debt and emerge from Chapter 11 owned by a group of investors. ... Read the full article on Seeking Alpha For further details see: ...
2024-06-23 20:39:26 ET Summary Harris Associates' 13F portfolio value increased from $58.03B to $61.82B this quarter, with around 200 positions reported. The top five stakes in the portfolio are Alphabet, IQVIA, Capital One Financial, Fiserv, and Intercontinental Exchange, totalin...
2024-06-22 12:50:35 ET With the 2024 U.S. presidential elections heating up next week in the form of the first debate, Goldman Sachs' portfolio strategy research team took a look at American companies which have the biggest exposure to domestic and international sales.... Read the ful...
2024-06-21 13:18:38 ET Summary CVS Health Corporation posted a horrid quarter. Management showed cracks in their integration model. Management's integration plan not panning out, recent performance issues, increased competition, and government scrutiny add complexity. I recomm...
2024-06-20 08:00:10 ET Andrew Mok from Barclays issued a price target of $65.00 for CVS on 2024-06-20 07:01:00. The adjusted price target was set to $65.00. At the time of the announcement, CVS was trading at $61.01. The overall price target consensus is at $109.15 with ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased securities of CVS Health Corporat...
CVS Health to hold second quarter 2024 earnings conference call PR Newswire WOONSOCKET, R.I. , July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 7 th , 2024, at 8:00 a.m. ET ...
2024-07-03 08:15:00 ET Some beaten-down stocks have significant upside potential and, therefore, present attractive buying opportunities for investors. However, other companies that are failing to keep pace with the market and are likely to keep struggling for a long time aren't worth inves...